Author:
Semenova A. V.,Popovicheva O. B.,Zavgorodnyaya Yu. A.,Chichaeva M. A.,Kovach R. G.,Kosheleva N. E.,Minkina T. M.,Kasimov N. S.
Reference52 articles.
1. M. S. Ali-Taleshi, A. R. Bakhtiari, M. Moeinaddini, et al., “Single-site source apportionment modeling of PM2.5-bound PAHs in the Tehran metropolitan area, Iran: Implications for source-specific multi-pathway cancer risk assessment,” Urban Clim. 39, 100928 (2021).
2. L. Yang, H. Zhang, X. Zhang, et al., “Exposure to atmospheric particulate matter-bound polycyclic aromatic hydrocarbons and their health effects: A review,” Int. J. Environ. Res. Public Health, No. 4, 2177 (2021).
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, “Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures,” IARC Monogr. Eval. Carcinog. Risks Hum. 92, 1–853 (2010).
4. Priority pollutant list, United States Environmental Protection Agency, 2014.
https://www.epa.gov/sites/default/files/2015-09/documents/priority-pollutant-list-epa.pdf
5. Provisional Guidance for Quantitative Risk Assessment of Polycyclic Aromatic Hydrocarbons (USEPA, 1993).